XML 18 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
Cash, cash equivalents, short-term investments, and restricted cash
3 Months Ended
Mar. 31, 2017
Cash, cash equivalents, short-term investments, and restricted cash  
Cash, cash equivalents, short-term investments and restricted cash

Note 3. Cash, cash equivalents, short-term investments, and restricted cash

 

The following table summarizes the Company’s cash, cash equivalents, short-term investments and restricted cash (in thousands):

 

 

 

 

 

 

 

 

 

 

    

March 31, 

    

December 31, 

 

 

 

2017

 

2016

 

Cash and cash equivalents:

 

 

 

 

 

 

 

Cash

 

$

57,890

 

$

58,691

 

Cash equivalents

 

 

23,809

 

 

23,809

 

Cash and cash equivalents

 

$

81,699

 

$

82,500

 

Short-term investments

 

$

6,047

 

$

19,015

 

Restricted cash

 

$

3,714

 

$

4,085

 

 

As of March 31, 2017 and December 31, 2016, restricted cash included approximately $2.0 million pursuant to an asset purchase agreement with Optoelectronics Components Co., Ltd. (“APAT OE”) relating to the asset sale closed in January 2017, in addition to the compensating balances relating to the Company’s notes payable issued under its line of credit facilities in China (see Note 8). The following table summarizes the Company’s unrealized gains and losses related to its cash equivalents and short-term investments in marketable securities designated as available-for-sale (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of March 31, 2017

 

As of December 31, 2016

 

 

 

 

Amortized Cost

 

Gross Unrealized Gains

 

Gross Unrealized Loss

 

Fair Value

 

Amortized Cost

 

Gross Unrealized Gains

 

Gross Unrealized Loss

 

Fair Value

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market accounts

 

$

23,809

 

$

 —

 

$

 —

 

$

23,809

 

$

23,809

 

$

 —

 

$

 —

 

$

23,809

 

Money market funds

 

 

2,306

 

 

 —

 

 

 —

 

 

2,306

 

 

199

 

 

 —

 

 

 —

 

 

199

 

Corporate debt securities

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

9,438

 

 

 4

 

 

(3)

 

 

9,439

 

Government agency securities

 

 

2,253

 

 

 —

 

 

(10)

 

 

2,243

 

 

3,767

 

 

 —

 

 

(10)

 

 

3,757

 

U.S. government securities

 

 

1,504

 

 

 —

 

 

(6)

 

 

1,498

 

 

5,008

 

 

 —

 

 

(10)

 

 

4,998

 

Sovereign government bonds

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

622

 

 

 —

 

 

 —

 

 

622

 

Total

 

$

29,872

 

$

 —

 

$

(16)

 

$

29,856

 

$

42,843

 

$

 4

 

$

(23)

 

$

42,824

 

Reported as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

$

23,809

 

$

 —

 

$

 —

 

$

23,809

 

$

23,809

 

$

 —

 

$

 —

 

$

23,809

 

Short-term investments

 

 

6,063

 

 

 —

 

 

(16)

 

 

6,047

 

 

19,034

 

 

 4

 

 

(23)

 

 

19,015

 

Total

 

$

29,872

 

$

 —

 

$

(16)

 

$

29,856

 

$

42,843

 

$

 4

 

$

(23)

 

$

42,824

 

 

Maturities of marketable securities were as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

    

March 31, 

    

December 31, 

 

 

 

2017

 

2016

 

Less than 1 year

 

$

26,115

 

$

36,054

 

Due in 1 to 2 years

 

 

3,741

 

 

6,468

 

Due in 3 to 5 years

 

 

 —

 

 

302

 

Total

 

$

29,856

 

$

42,824

 

 

Realized gains and losses on the sale of marketable securities during the three months ended March 31, 2017 and 2016 were immaterial. The Company did not recognize any impairment losses on its marketable securities during the three months ended March 31, 2017 or 2016. As of March 31, 2017 and December 31, 2016, the Company did not have any investments in marketable securities that were in an unrealized loss position for a period in excess of 12 months.